Lipoprotein derangement during steroid treatment in minimal-change nephrotic syndrome?

Nephron

Volumn 73, Issue 4, 1996, Pages 606-612

  Tsukamoto, Yusuke ^a   Kokubo, Tooru ^a   Horii, Akira ^a   Moriya, Rika ^a   Kobayashi, Yutaka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

High density protein; Hyperlipidemia; Lecithin cholesterol acyltransferase; Low density lipoprotein; Minimal change disease; Nephrotic syndrome

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; STEROID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; STEROID THERAPY;

ADULT; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS; CHOLESTEROL; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; NEPHROSIS, LIPOID; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; PROTEINURIA; TRIGLYCERIDES;

EID: 0029782161     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189148     Document Type: Article

References (31)

1. Appel GB. Valeri A. Appel AS. Blum C: The hypcrlipidemia of ihe nephrotic syndrome. Am J Med 1989;87:S45N-S50N.
2. Marsh JB. Sparks CE: Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis. J Clin Invest 1979:64:1229-1237.
3. Gherardi E. Messori M. Rozzi R. Calandra S: Experimental nephrotic syndrome in the rat induced by puromycin aminonuclcosidc: Hepatic synthesis of lipoproteins and apoproteins. Lipids 1980:15:858-863.
4. Calandra S. Gherardi E. Fainaru M, Guaitani A. Bartosek I: Secretion of lipoproteins, apoli-poprotein A-l and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. Biochim Biophys Acta 1981;665:331-338.
5. Diamant S, Shafrir E: Lipogencsis in antinonu-clcoside-induced nephrotic syndrome. Biochim Biophys Acta 1974:360:241-251.
6. McKenzie IFC, Nestel PJ: Studies on the turnover of triglyceride and cstcrified cholesterol in subjects with the nephrotic syndrome. J Clin Invest 1968:47:1685-1695.
7. Gitlin D. Cornwell DG. Nakasato D. Oncley JL. Hughes WL. Janeway CA: Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins. J Clin Invest 1958:37:172-184.
8. Cohen L, Cramp DG. Lewis AD. Tickner TR: The mechanism of hypcrlipidemia in nephrotic syndrome: Role of low albumin and the LCAT reaction. Clin Chim Acta 1980:104:393-400.
9. Chan MK. Varghese Z. Persaud JM. Moorhead JF: Posthepatic and lipoprotein lipase activities in nephrotic syndromes. Aust NZ J Med 1984.,14:841-847.
10. Nikkila EA. Grasbeck R: Heparin in lipoid nephrosis: Observations of the effects on edema. proteinuria, serum proteins, lipids and lipoproteins. Acta Med Scand 1954:150:39-46.
11. Appel GB. Blum CB. Chien S. Kunis CL. Appel AS: The hypcrlipidemia of the nephrotic syndrome: Relation to plasma albumin concentration, oncotic pressure, and viscosity. N Engl J Med 1985;312:1544-1548.
12. Short CD. Durrington PN, Mallick NP. Hunt LP, Tetlow L, Ishola M: Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney Int 1986:29:1224-1228.
13. Lopes-Virclla M, Virclla G, DcBcukclacr M. Owens CJ, Colwell JA: Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies. Clin Chim Acta 1979:94:73-81.
14. Zilleruclo G, Hsia SL. Freundlich M, Gorman HM, Strauss J: Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr 1984:104:61-64.
15. Yedgar S. Weinstein DB. Patsch W. Schonfcld G, Casanda FE, Steinberg D: Viscosity of culture medium as a regulator of synthesis and secretion of very low density lipoproteins by cultured hepatocytes. J Biol Chcm 1982:257: 2188-2192.
16. Kekki M. Nikkila EA: Plasma triglyceride metabolism in the adult nephrotic syndrome. Eur J Clin Invest 1971;1:345-351.
17. Levy E. Ziv E. Bar-On H, Shafrir E: Experimental nephrotic syndrome: Removal and tissue distribution of chylomicrons and vcry-low-density lipoproteins of normal and nephrotic origin. Biochim Biophvs Acta 1990:1043:259-266.
18. Havel RJ. Eder HA. Bragdon JH: The distribution and chemical composition of ullracentri-fugally separated lipoproteins in human serum.,., I Clin Invest 1955;34:1345-1353.
19. Goto Y. Akanuma Y, Harano Y: Determination by the SRID method of normal values of serum apolipoprotcins(A-I. A-ll. B, C-II. C-III. and E) in normalipidcmic healthy Japanese subjects. J Clin Biochcm Nutr 1986:1:73-88.
20. Nagasaki T. Akanuma Y: A new calorimetrie method for the determination of plasma leci-thin-cholesterol acyltransfcrasc activity. Clin Chim Acta 1977;75:371-375.
21. Shafrir E, Brenner T: Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis. I. Studies in rat in vivo. Lipids 1979;14:695-702.
22. Golper TA. Swartz SH: Impaired renal nicva-lonatc metabolism in nephrotic syndrome: A stimulus for increased hepatic cholcstcrogcnc-sis independent of GFR and hypoalbuminem-ia. Metabolism 1982:31:471-476.
23. Newmark S. Anderson CF. Donadio IV. Ellef-son RD.: Lipoprotein profiles in adult nephrosis. Mayo Clin Proc 1975:50:359-364.
24. Chopra JS, Mallick NP: Hyperlipoproteinemias in nephrotic syndrome. Lancet 1971;i: 317-320.
25. Gordon V. lnncrality TL, Mahlev RW: Formation of cholesterol-and apolipoprotein E-cn-riched high density lipoprotein in vivo. J Biol Chem 1983:258:6202-6212.
26. Shore VG. Forte T. Licht H. Lewis SB: Serum and urinary lipoproteins in the human nephrotic syndrome: Evidence for renal catabolism of lipoprotein. Metabolism 1982:31:258-268.
27. Saku K, Mendoza SG. Laver M, Hynd BA. Gartside PS, Kashyap ML: High-dcnsity lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria. Nephron 1988.,50:112-115.
28. Appel G: Lipid abnormalities in renal disease. Kidney Int 1991:39:169-183.
29. Wheeler DCB: Lipid abnormalities in the nephrotic syndrome: Causes, consequences, and treatment. Am J Kidney Dis 1994:23:331-346.
30. Brcckenridge WC. Little JA. Steiner G. Chow A, Poapst M: Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 1978:298:1265-1273.
31. Pirsch JD. D'Alcssandro AM. Sollingcr HW. Kncchtle SJ, Reed A, Kalavoglu M. Beizer FO: Hvperlipidcmia and transplantation: Eliologic factors and therapy. J Am Soc Nephrol 1992:2: S238-S242.